Pharmafile Logo
Pharmafocus logo
Advanced Search

Unlocking nature’s pharmacy: how tea leaves and marine organisms could help transform breast cancer treatment

October 2, 2025
Research and Development King Abdullah University of Science and Technology, Oncology, natural products chemistry, triple-negative breast cancer

Looking beyond synthetic chemistry to unlock powerful, naturally derived medicines Each year, World Breast Cancer Awareness Month serves as a …

Feature

Sanofi and Regeneron’s Dupixent receives CHMP recommendation for chronic spontaneous urticaria

September 26, 2025
Research and Development Dupixent, Regeneron, Sanofi, urticaria

Sanofi and Regeneron have received a positive opinion from the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human …

News
hsm_mobile_clinical_trial_istock-872676342

CSL Behring’s angioedema treatments receives NICE recommendation

September 26, 2025
Regulatory Affairs, Research and Development Andembry, CSL Behring, hereditary angioedema

The National Institute for Health and Care Excellence (NICE) has issued final draft guidance recommending CSL Behring’s ANDEMBRY (garadacimab) for …

News
drug-trials

Gilead Foundation awards $6.5m in grants to support STEM education

September 26, 2025
Research and Development Funding and Investment, Gilead Sciences, stem

Gilead Sciences has committed over $6.5m in grant funding towards improving science, technology, engineering and maths (STEM) education, the company …

News

Lilly opens fourth US Gateway Labs site

September 26, 2025
Research and Development Eli Lilly, Local Investment, biotech, life sciences

Eli Lilly has opened its newest Lilly Gateway Labs (LGL) site in San Diego, California, expanding its network of shared …

News
partnership

Arkivum and PHARMASEAL partner on trial management platform

September 26, 2025
Research and Development Arkivum, PHARMASEAL, Trial Management

Arkivum, a digital archiving and preservation solutions provider, has entered into a collaborative agreement with PHARMASEAL, a software company specialising …

News

Combination treatments: Takeda’s Implementation Framework and the broader landscape

September 23, 2025
Research and Development HIV/AIDS, Hepatology, NHS, NICE, Oncology, Takeda, combination therapy, oncology

Pharmafile talks to Emma Roffe, Oncology Country Head (UK & Ireland) about the combination treatment landscape and the impact of …

Feature
drug-trials

LGC Group opens $100M Organic Chemistry Synthesis Centre of Excellence

September 19, 2025
Medical Communications, Research and Development LGC Group, biotech, life sciences, pharma

LGC Group, a life sciences company, has opened its new Organic Chemistry Synthesis Centre of Excellence in Ontario, Canada after …

News
Lilly secures conditional MHRA approval for new blood cancer treatment

Crown Bioscience opens new US model development centre

September 19, 2025
Medical Communications, Research and Development CRO, biotech, crown bioscience, life sciences

Crown Bioscience, a US global contract research organisation (CRO) that is part of JSR Life Sciences and Japan-based JSR Corporation, …

News

UCB announces first-in-patient trial success for galvokimig in atopic dermatitis

September 18, 2025
Medical Communications, Research and Development Dermatology, UCB, atopic dermatitis, clinical trial

UCB has reported positive early clinical trial results for galvokimig, an investigational therapy for adults with moderate-to-severe atopic dermatitis (AD). …

News
mobile apps

electronRx to launch pDx app for remote monitoring of chronic respiratory disease

September 18, 2025
Research and Development Asthma & COPD, Devices, devices, electronRx, pDx, respiratory diseases (CRDs)

Digital medicine company electronRx, based in Cambridge, UK, has announced the upcoming launch of pDx, a mobile app designed to …

News

ProteoNic Biosciences launches platform to enhance cell line productivity

September 17, 2025
Research and Development Devices, ProteoNic Biosciences, cell line productivity, gene therapy

ProteoNic Biosciences, a biotech company headquartered in Leiden, Germany has unveiled its latest technology platform, the 2G UNic transposon system, developed …

News
handshake-2056023_960_720

NeoVac appoints Jan H Egberts as chief executive officer

September 17, 2025
Analytical & Laboratory Services, Business Services, Clinical Trial Services, Research and Development Devices, Lipid Nanoparticle Technology, Neovac, mRNA Therapies

NeoVac, a clinical-stage biopharma based in Abingdon, UK, has appointed Jan H Egberts as chief executive officer. The company is …

Appointment

PlasmidFactory founder Dr. Martin Schleef honoured with the NRW Innovation Award 2025

September 12, 2025
Innovation Award 2025, PlasmidFactory, cell and gene therapy, medical communications, research and development

The founder and long-standing CEO of PlasmidFactory, Dr. Martin Schleef, was honoured in Düsseldorf with the Innovation Award 2025 of …

News
Lilly secures conditional MHRA approval for new blood cancer treatment

Symeres announces acquisition of DGr Pharma

September 11, 2025
Medical Communications, Research and Development DGr Pharma, Symeres, biopharma, contract research

Symeres, a Contract Research, Development and Manufacturing Organization (CRDMO) has acquired DGr Pharma, a drug development-focused consultancy. The acquisition will …

News

Danny Wolin appointed as KJT’s Senior VP of real-world evidence

September 11, 2025
Medical Communications, Research and Development KJT, real-world evidence

Danny Wolin has been appointed as Senior Vice President of Real-World Evidence at KJT. KJT is an evidence-based healthcare consulting …

Appointment

Brian Adams appointed as Kymera’s CLO and Corporate Secretary

September 11, 2025
Kymera, biopharma, corporate, immunology

Brian Adams has been appointed as Kymera Therapeutics’ Chief Legal Officer (CLO) and Corporate Secretary. He will lead Kymera’s legal, …

Appointment

Sapio Sciences and Ultima Genomics form multi-omics research partnership

September 11, 2025
Medical Communications, Research and Development Sapio Sciences, Ultima Genomics, biotech, genomics research

Sapio Sciences and Ultima Genomics have formed a strategic partnership to accelerate genomics research. The collaboration aims to make multi-omics …

News

Richmond Pharmacology promotes Patrick Ramiah to Director

September 8, 2025
Clinical Trial Services, Director of Clinical Project Delivery & Operational Excellence, Richmond Pharmacology, corporate, research and development

Patrick Ramiah has been promoted to Director of Clinical Project Delivery & Operational Excellence at Richmond Pharmacology, effective from 1 …

Appointment
drug-trials

MultiOmic Health and BIO4 Campus sign collaborative Memorandum of Understanding

September 8, 2025
Medical Communications, Research and Development AI, BIO4 Campus, Memorandum of Understanding, MultiOmic Health, biotech

MultiOmic Health (MOH), an artificial intelligence (AI)-enabled precision medicine biotechnology company and BIO4 Campus (BIO4), a biotechnology and life sciences …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025